CIK 0001604464
- Non-accelerated filer
- Smaller reporting company
Atara Biotherapeutics, Inc.
Sign in to watch- Ticker
- ATRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460920988
- Phone
- +1 805-623-4211
- Business address
- 1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
- Open-market buys, last 90 days
- $999,994
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$999,994. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-03-27 | Clark Mitchall G. EVP & Chief R & QA Officer | Option exercise · Employee Stock Option (Right to Buy) | −28,848 | 11,194 | ||
| 2018-03-27 | Clark Mitchall G. EVP & Chief R & QA Officer | Option exercise · Employee Stock Option (Right to Buy) | −32,500 | 32,500 | ||
| 2018-03-27 | Clark Mitchall G. EVP & Chief R & QA Officer | Option exercise · Employee Stock Option (Right to Buy) | −11,406 | 3,125 | ||
| 2018-03-27 | Ciechanover Isaac E. Chief Executive Officer | Sale | −2,700 | $36.63 | $99K | 208,178 |
| 2018-03-27 | Ciechanover Isaac E. Chief Executive Officer | Sale | −1,500 | $37.68 | $57K | 206,678 |
| 2018-03-27 | Ciechanover Isaac E. Chief Executive Officer | Sale | −200 | $38.40 | $8K | 206,478 |
| 2018-03-26 | Ciechanover Isaac E. Chief Executive Officer | Sale | −3,200 | $39.72 | $127K | 212,078 |
| 2018-03-26 | Ciechanover Isaac E. Chief Executive Officer | Sale | −1,200 | $41.12 | $49K | 210,878 |
| 2018-03-26 | Haqq Christopher EVP, R&D & Chief Scientific Of | Sale | −17,227 | $39.76 | $685K | 334,005 |
| 2018-03-26 | Haqq Christopher EVP, R&D & Chief Scientific Of | Sale | −1,100 | $40.29 | $44K | 332,905 |
| 2018-03-20 | MCGRATH JOHN EVP & Chief Financial Officer | Sale | −3,000 | $38.83 | $116K | 88,762 |
| 2018-03-19 | MCGRATH JOHN EVP & Chief Financial Officer | Sale | −3,000 | $41.99 | $126K | 91,762 |
| 2018-03-16 | Ciechanover Isaac E. Chief Executive Officer | Sale | −3,100 | $41.75 | $129K | 216,578 |
| 2018-03-16 | Ciechanover Isaac E. Chief Executive Officer | Sale | −1,300 | $42.59 | $55K | 215,278 |
| 2018-03-15 | Ciechanover Isaac E. Chief Executive Officer | Sale | −2,800 | $41.87 | $117K | 221,278 |
| 2018-03-15 | Ciechanover Isaac E. Chief Executive Officer | Sale | −1,600 | $42.95 | $69K | 219,678 |
| 2018-03-12 | Ciechanover Isaac E. Chief Executive Officer | Sale | −700 | $46.17 | $32K | 224,378 |
| 2018-03-12 | Ciechanover Isaac E. Chief Executive Officer | Sale | −300 | $46.65 | $14K | 224,078 |
| 2018-02-22 | Ciechanover Isaac E. Chief Executive Officer | Sale | −1,600 | $42.74 | $68K | 228,078 |
| 2018-02-22 | Ciechanover Isaac E. Chief Executive Officer | Sale | −1,600 | $44.03 | $70K | 226,478 |
Page 33 of 44 · 867 trades